Bioline Rx reported $13.67M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Arca Biopharma USD 15.37M 5.59M Dec/2025
Bio Path USD 8.68M 819K Sep/2025
Bioline Rx USD 13.67M 1.81M Sep/2025
Capricor Therapeutics USD 35.84M 7.69M Dec/2025